Spin-Off and Innovation in the Pharmaceutical Industry
Parent companies usually undertake corporate spin-offs to cope with higher competitive environments or when, in high technology industries, the differences between R&D investments and intangible assets are larger. Consistent with the recent “positive view“, spin-offs can be considered as a “proa...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2014-11-01
|
| Series: | International Journal of Engineering Business Management |
| Online Access: | https://doi.org/10.5772/59019 |